
Regulatory flexibility can make continuous improvement possible.
Mark Rosolowsky is the executive director of global regulatory sciencesâCMC at Bristol Myers Squibb

Regulatory flexibility can make continuous improvement possible.

Second in a three-part series that discusses the complexities of QbD implementation in biotech development.

First in a three-part series that discusses the complexities of QbD implementation in biotech product development.

Published: January 1st 2010 | Updated:

Published: December 1st 2009 | Updated:

Published: November 1st 2009 | Updated: